�� IMAGE PLACEHOLDER: Hero Image: A hematologist reviewing blood cell analysis results on a large monitor in a clinical laboratory setting, with patients visible in the background infusion suite. Caption: Hematology Billing Services — Expert Revenue Cycle Management for Blood Disorder & Hematologic Malignancy Practices.
Hematology is a specialty where the science is complex, the stakes are high, and the billing, if done incorrectly, costs your medical practice far more than most you realize. Whether your practice manages iron deficiency anemia, sickle cell disease, myelodysplastic syndromes, clotting disorders, or hematologic malignancies like leukemia and lymphoma, every patient encounter carries a dense web of CPT codes, ICD-10 diagnoses, HCPCS drug codes, infusion timing requirements, and prior authorization obligations.
We have written this guide for US hematologists, hematology-oncology physicians, practice managers, and administrators who want a clear, authoritative, and immediately actionable resource on hematology billing services.
And at the end, we will show you why House of Outsourcing is the trusted billing partner that hematology practices across the United States turn to when they need results.
Hematology medical billing sits at the intersection of diagnostic medicine, procedural care, and high-cost drug administration, and each of those three areas comes with its own set of coding rules, payer requirements, and compliance obligations. No other non-surgical specialty demands the same breadth of coding expertise in a single practice setting.
Here are the key factors that makes our hematology billing services a genuine specialty within medical billing:
As an experienced healthcare professional you know that in hematology, the ICD-10-CM diagnosis code is not a formality, it is the clinical justification that determines whether payers will authorize and reimburse every procedure, drug, and service your practice provides. Using unspecified or incorrect diagnosis codes in hematology billing is one of the leading causes of medical necessity denials.
| ICD-10 Range | Category | Examples in Hematology Practice |
|---|---|---|
| D50–D53 | Nutritional Anemias | D50.0 Iron deficiency anemia due to blood loss (chronic); D52.0 Dietary folate deficiency anemia; D53.9 Unspecified nutritional anemia |
| D55–D58 | Hemolytic Anemias | D57.1 Sickle-cell disease without crisis; D57.00 Hb-SS with crisis, unspecified; D58.0 Hereditary spherocytosis |
| D59 | Acquired Hemolytic Anemias | D59.0 Drug-induced autoimmune hemolytic anemia; D59.11 Warm antibody autoimmune hemolytic anemia (WAIHA) |
| D60–D64 | Aplastic & Other Anemias | D61.1 Drug-induced aplastic anemia; D61.3 Idiopathic aplastic anemia; D64.9 Anemia, unspecified |
| D65–D69 | Coagulation Defects | D66 Hereditary factor VIII deficiency (hemophilia A); D68.0 Von Willebrand disease; D68.311 Acquired hemophilia |
| D70–D77 | Other Blood Disorders | D70.0 Congenital agranulocytosis; D72.829 Lymphocytosis; D75.0 Familial erythrocytosis |
| D80–D89 | Immune Disorders | D83.9 Common variable immunodeficiency; D84.9 Immunodeficiency, unspecified; D89.810 GVHD |
| C81–C86 | Lymphomas | C81.90 Hodgkin lymphoma, unspecified; C83.30 Diffuse large B-cell lymphoma; C85.90 Non-Hodgkin lymphoma, unspecified |
| C91–C95 | Leukemias | C91.00 Acute lymphoblastic leukemia; C92.00 Acute myeloid leukemia; C95.90 Leukemia, unspecified |
| C88–C90 | Plasma Cell Neoplasms | C90.00 Multiple myeloma, not in remission; C90.10 Plasma cell leukemia; C88.2 Heavy chain disease |
| D46 | Myelodysplastic Syndromes | D46.0 Refractory anemia without RS; D46.20 Refractory anemia with excess blasts; D46.9 MDS, unspecified |
| D47 | Neoplasms of Uncertain Behavior | D47.1 Chronic myeloproliferative disease; D47.3 Essential thrombocythemia; D47.4 Osteomyelofibrosis |
�� Tip: Code to the Highest Specificity Available in Hematology
Hematology diagnosis codes demand the highest possible specificity. For example, sickle cell disease has dozens of ICD-10 sub-codes based on genotype (Hb-SS, Hb-SC, sickle-beta thalassemia) and crisis type (with crisis, without crisis, with acute chest syndrome). Payers use these distinctions to determine medical necessity for high-cost treatments like hydroxyurea, voxelotor, or crizanlizumab infusions. Using D57.1 (‘Sickle-cell disease without crisis’) when the patient is in crisis (D57.00) is both clinically inaccurate and a compliance risk. Always code from the clinical documentation — not the superbill checkbox.
CPT code selection in hematology billing covers three main categories: procedural codes for bone marrow and other hematologic procedures, infusion and administration codes, and evaluation and management codes. Each category has its own coding rules and documentation requirements.
Bone marrow aspiration and biopsy are among the highest-volume and highest-value procedures in hematology. Correct coding depends on what was performed, aspiration alone, biopsy alone, or both, and whether the physician also interpreted the specimen.
| CPT Code | Procedure Description | Critical Billing Notes |
|---|---|---|
| 38220 | Bone marrow aspiration | Aspiration alone; document site (iliac crest, sternum), technique, and yield |
| 38221 | Bone marrow biopsy, needle or trocar | Biopsy alone (core biopsy); document site and number of cores obtained |
| 38222 | Bone marrow biopsy and aspiration | Both performed; bill 38222 rather than 38220 + 38221 when both done at same session |
| 38230 | Bone marrow harvesting for transplant — allogeneic | Document donor type, collection volume, and transplant indication |
| 38232 | Bone marrow harvesting for transplant — autologous | Document autologous collection; often requires separate facility billing |
| 38240 | Hematopoietic progenitor cell (HPC) transplant — allogeneic | High-cost procedure; requires PA and transplant center documentation |
| 38241 | HPC transplant — autologous | Document mobilization, collection, and infusion dates separately |
| 38242 | Allogeneic lymphocyte infusions | Document donor, lymphocyte dose (cells/kg), and clinical indication |
| 85097 | Bone marrow interpretation and report | Professional component — bill when physician interprets BM specimen |
| 88182 | Flow cytometry, each cell surface marker (technical) | Bill per marker analyzed; professional interpretation billed separately |
| 88184 | Flow cytometry, first marker — professional | Professional component of flow cytometry interpretation |
�� Tip: Bill 38222 — Not 38220 + 38221 — When Both Are Performed
When a physician performs both a bone marrow aspiration and a needle biopsy at the same session, the correct code is 38222 — not a combination of 38220 and 38221. Billing 38220 and 38221 separately when 38222 applies is a CCI bundling violation. However, if the aspiration and biopsy are performed at different anatomical sites during the same session, separate billing may be appropriate with modifier -59 or -XS and thorough documentation.
| CPT Code | Test Description | Billing Note |
|---|---|---|
| 85025 | Complete Blood Count (CBC) with automated differential | Most common hematology lab; document clinical indication |
| 85027 | CBC without automated differential | Use 85027 only when differential not performed or ordered |
| 85610 | Prothrombin time (PT) | Coagulation monitoring; frequent in anticoagulation management |
| 85730 | Partial thromboplastin time (PTT/APTT) | Key coagulation test; document indication (monitoring vs. diagnosis) |
| 85651 | Erythrocyte sedimentation rate (ESR), non-automated | Inflammation marker; code 85652 for automated method |
| 83615 | Lactate dehydrogenase (LDH) | Elevated in hemolysis, lymphoma, and leukemia — document clinical context |
| 86367 | Stem cell enumeration — each antibody | CD34+ cell counting for transplant planning |
| 86355 | B cells, total count | Lymphocyte subset panel — document immunodeficiency or malignancy indication |
| 86356 | MHC class II antigen testing | HLA typing for transplant compatibility — requires separate PA |
| 81219 | CALR (calreticulin) gene analysis | Molecular test for myeloproliferative neoplasms |
| 81270 | JAK2 gene analysis (V617F variant) | Essential for polycythemia vera diagnosis; document testing indication |
| 81245 | FLT3 gene analysis | AML molecular testing; required for targeted therapy selection |
| CPT Code | Visit Type | MDM Complexity | Common Hematology Use |
|---|---|---|---|
| 99213 | Established patient — office | Low | Routine CBC follow-up, simple anemia monitoring |
| 99214 | Established patient — office | Moderate | Chronic ITP management, anticoagulation follow-up |
| 99215 | Established patient — office | High | Complex MDS, leukemia management, multiple medications |
| 99204 | New patient — office | Moderate | New referral for anemia workup or clotting disorder |
| 99205 | New patient — office | High | Complex new patient: MDS, lymphoma, hemophilia |
| 99221-99223 | Initial hospital care | Low/Mod/High | Inpatient admission for hematologic emergency or transplant |
| 99231-99233 | Subsequent hospital care | Low/Mod/High | Daily inpatient management during transplant or acute leukemia |
�� IMAGE PLACEHOLDER: Image 1: A professional infographic showing the three major CPT code categories in Hematology — Bone Marrow Procedures, Laboratory/Diagnostics, and Infusion Administration — in a visual hierarchy with color coding. Caption: Hematology Billing Services — The Three CPT Code Pillars Every Hematology Practice Must Master.
For most hematology practices, infusion billing represents the largest single component of revenue, and the highest-risk area for billing errors, denials, and compliance investigations. High-cost biologic therapies, blood factors, and supportive medications administered in your infusion suite carry reimbursements that dwarf most office-based services, which is exactly why payers scrutinize every unit billed.
Infusion administration codes are time-based and hierarchical. They must be billed in a specific order, with start and stop times documented for every drug and every infusion session. There is no flexibility here missing time documentation means a non-compliant claim.
| CPT Code | Administration Description | Key Hematology Billing Rule |
|---|---|---|
| 96413 | Chemotherapy infusion — initial, up to 1 hour | Use for antineoplastic agents; document drug name, dose, route, start/stop times |
| 96415 | Chemotherapy infusion — each additional hour | Add-on to 96413; bill per additional hour; must document extended time |
| 96401 | Chemotherapy injection — non-infusion, non-hormonal | Subcutaneous or intramuscular; not time-based; document route and drug |
| 96402 | Hormonal antineoplastic agent injection | Leuprolide, degarelix, fulvestrant; document drug, dose, and indication |
| 96365 | Non-chemo therapeutic infusion — initial, up to 1 hour | Immunoglobulin (IVIG), iron infusion, zoledronic acid, rituximab (non-chemo use) |
| 96366 | Non-chemo therapeutic infusion — each additional hour | Add-on; time-based; document extended infusion time |
| 96367 | Therapeutic infusion — additional sequential drug | Second drug, infused sequentially; document sequence and time |
| 96368 | Therapeutic infusion — concurrent | Same IV line, concurrent with primary infusion; limited to once per encounter |
| 96360 | Hydration infusion — initial, 31 min to 1 hour | Pre- or post-chemo hydration; cannot be reported alone if only hydration |
| 96361 | Hydration infusion — each additional hour | Add-on; document medical necessity for extended hydration |
| 96372 | Therapeutic, prophylactic or diagnostic injection — SC or IM | Non-antineoplastic SC/IM injections; includes epo-stimulating agents, G-CSF |
J-codes are HCPCS Level II codes used to bill for the actual drugs administered in your hematology practice. In a specialty where a single infusion of a biologic agent can cost $15,000 to $50,000 or more, J-code accuracy is not a coding exercise, it is a financial imperative.
| J-Code | Drug / Agent | Critical Billing Notes |
|---|---|---|
| J0881 | Darbepoetin alfa (Aranesp) — 1 mcg | Report actual mcg administered; NOT dose ordered. PA required for non-dialysis patients |
| J0885 | Epoetin alfa (Epogen/Procrit) — 1000 units | Report actual units given; round to nearest 100 units administered |
| J0897 | Denosumab (Xgeva) — 1 mg | Used in multiple myeloma bone protection; document oncology indication |
| J9034 | Bendamustine HCl (Treanda) — 1 mg | Chemotherapy; document dose in mg/m2 and total mg administered |
| J9055 | Bortezomib (Velcade) — 0.1 mg | Multiple myeloma; SC injection; document BSA-based dosing |
| J9145 | Daratumumab (Darzalex) — 10 mg | Myeloma biologic; very high cost; always verify PA before administration |
| J9229 | Ibrutinib (Imbruvica) — 140 mg | Oral oncolytic — billed per actual capsule dispensed; Medicare Part D consideration |
| J9306 | Rituximab (Rituxan) — 100 mg | Lymphoma and autoimmune; bill per 100 mg units; PA required |
| J1459 | IVIG — immune globulin, 500 mg | Used in ITP, AIHA, CIDP; PA required; bill actual grams administered |
| J0897 | Factor VIII (antihemophilic) — 1 IU | Hemophilia A; extremely high cost; units billed must match infusion record exactly |
| J7195 | Factor IX complex — 1 IU | Hemophilia B; document IU administered; PA required from all payers |
| J0217 | Atezolizumab (Tecentriq) — 10 mg | Immunotherapy; document indication (hematologic vs. solid tumor) |
| Q2049 | Infliximab biosimilar — per 10 mg | Biosimilar of Remicade; ensure correct biosimilar J-code — do not use J1745 if biosimilar dispensed |
�� Biosimilar Billing Alert
Biosimilar drugs have their own separate J-codes that are different from the reference biologic J-code. Billing J9306 (Rituximab-Rituxan) when you actually administered a rituximab biosimilar (e.g., Ruxience – Q5119 or Truxima – Q5115) is a J-code error that can result in claim denial, incorrect reimbursement, and audit exposure. As biosimilars become standard of care in hematology, keeping your J-code formulary current is a monthly responsibility — not an annual one. Review HCPCS biosimilar code updates quarterly.
| CPT Code | Procedure | Billing Note |
|---|---|---|
| 36556 | Insertion of non-tunneled central venous catheter, age 5+ | Bill 36556 for non-tunneled; 36558 for tunneled |
| 36558 | Insertion of tunneled centrally inserted central venous catheter (CVC) | Tunneled vs. non-tunneled distinction is critical — different code, different RVU |
| 36570 | Insertion of peripherally inserted central venous catheter (PICC) | Document age and approach; imaging guidance billed separately |
| 10140 | Incision and drainage (I&D) of hematoma, seroma, or fluid collection | Simple I&D; document size and content of collection |
| 11042-11047 | Debridement codes — subcutaneous, fascia, muscle | Bill by depth and surface area; use add-on codes 11045-11047 for additional sq cm |
| 49000 | Exploratory laparotomy | Used when no specific intraabdominal procedure performed — requires complete documentation |
| 49021 | Drainage of peritoneal abscess or localized peritonitis, open | Distinguish from percutaneous drainage; document open approach |
�� IMAGE PLACEHOLDER: Image 1: A professional infographic showing the major categories of General Surgery CPT codes — Abdominal, Hernia, Breast, Thyroid, and Vascular Access — organized in a clean visual hierarchy. Caption: General Surgery Billing Services — Essential CPT Code Categories for Every Surgical Practice.
�� IMAGE PLACEHOLDER: Image 1: A professional infographic showing the major categories of General Surgery CPT codes — Abdominal, Hernia, Breast, Thyroid, and Vascular Access — organized in a clean visual hierarchy. Caption: General Surgery Billing Services — Essential CPT Code Categories for Every Surgical Practice.
We know that accurate ICD-10-CM coding is the clinical backbone of your general surgery claim. Every CPT procedure code must be supported by a diagnosis code that demonstrates medical necessity. Using unspecified or mismatched diagnosis codes is one of the most reliable ways to trigger a medical necessity denial.
| ICD-10 Code | Diagnosis Description | Common Associated Procedure |
|---|---|---|
| K80.20 | Calculus of gallbladder without cholecystitis, without obstruction | Laparoscopic cholecystectomy (47562) |
| K81.0 | Acute cholecystitis | Emergent laparoscopic or open cholecystectomy (47562/47600) |
| K35.2 | Acute appendicitis with generalized peritonitis | Appendectomy (44960) — ruptured/complicated |
| K37 | Unspecified appendicitis | Appendectomy (44950) — use K37 only when appendicitis not further specified |
| K40.90 | Unilateral inguinal hernia, initial encounter, without obstruction | Inguinal hernia repair (49505/49650) |
| K43.0 | Incisional hernia with obstruction, without gangrene | Incisional hernia repair (49560/49565) — document obstruction |
| C50.911 | Malignant neoplasm of right breast, unspecified | Mastectomy (19303/19305) — specify laterality with RT/LT modifier |
| D13.39 | Benign neoplasm of other parts of small intestine | Small bowel resection (44120) — document benign vs. malignant |
| E04.1 | Nontoxic single thyroid nodule | Thyroid lobectomy (60220) |
| C73 | Malignant neoplasm of thyroid gland | Total thyroidectomy for malignancy (60252) |
| K57.20 | Diverticulosis of large intestine with perforation, without abscess | Emergent colectomy (44140/44204) |
| L02.211 | Cutaneous abscess of abdominal wall | I&D (10060); document location specifically |
�� Tip: Always Use the 7th Character for Trauma Cases
For injury and trauma diagnoses in general surgery, lacerations, fractures, contusions, foreign bodies — ICD-10-CM requires a 7th character to indicate the encounter type: ‘A’ for initial encounter, ‘D’ for subsequent encounter, and ‘S’ for sequela. Using the wrong 7th character is a common coding error in general surgery emergency cases that results in claim rejection. Train your coders to always confirm the 7th character matches the clinical documentation.
As an experienced surgeon you know that in general surgery billing, modifiers are not optional add-ons, they are essential tools that communicate critical information about the circumstances of every surgical case. Used correctly, they unlock reimbursement for additional services, protect you from global period bundling, and prevent denials.
| Modifier | Name | When to Use in General Surgery Billing |
|---|---|---|
| -22 | Increased Procedural Services | Surgery was substantially more complex than typically described by the CPT code. Requires detailed operative note explaining increased complexity. Expect payer to review before paying premium. |
| -23 | Unusual Anesthesia | General anesthesia required for a procedure normally done under local. Document medical necessity for general anesthesia. |
| -24 | Unrelated E/M During Post-Op Period | Office visit during the global period for a condition UNRELATED to the surgery. Document clearly that the issue is unrelated. |
| -25 | Significant, Separately Identifiable E/M | When same-day E/M is separate and significant from the procedure performed. Common in general surgery for decision-to-operate visits. |
| -47 | Anesthesia by Surgeon | Surgeon personally administered regional/general anesthesia — rare, but applicable in some settings. |
| -50 | Bilateral Procedure | Same procedure performed on bilateral anatomical structures in same session. Applies to bilateral hernia repair or bilateral breast procedures. |
| -51 | Multiple Procedures | Second and subsequent procedures in same session, same provider. Primary procedure = no modifier; subsequent procedures get -51. |
| -52 | Reduced Services | Procedure partially performed or reduced at surgeon's discretion. Document reason clearly in the operative note. |
| -53 | Discontinued Procedure | Procedure started but stopped due to patient safety. More significant than -52; applies when procedure could not be completed. |
| -54 | Surgical Care Only | Surgeon provides surgical care only; post-op care transferred to another physician. |
| -55 | Post-Operative Management Only | Receiving physician provides post-op care only — does not perform surgery. |
| -56 | Pre-Operative Management Only | Rare; surgeon provides only pre-op care, another surgeon performs the operation. |
| -57 | Decision for Surgery | E/M visit at which the decision for major surgery was made, within the global period of another procedure. Prevents bundling of decision visit. |
| -58 | Staged or Related Procedure (Planned) | Return to OR during global period for a planned staged procedure — documented as planned at time of original surgery. |
| -59 | Distinct Procedural Service | Procedures that are normally bundled but are clinically distinct. Use -XS, -XE, -XP, or -XU as more specific alternatives when applicable. |
| -62 | Two Surgeons / Co-Surgeons | Two surgeons of different specialties each perform distinct parts of a surgical procedure. Each bills with -62. |
| -66 | Surgical Team | Complex procedure requiring team of surgeons. Each bills with -66. Requires clear operative documentation of each surgeon's role. |
| -78 | Return to OR — Related Complication (Unplanned) | Unplanned return to OR during global period for complication of original surgery. |
| -79 | Unrelated Procedure During Global Period | Return to OR during global period for a condition COMPLETELY UNRELATED to the original surgery. |
| -80 | Assistant Surgeon | Another physician assists the primary surgeon. Bill assistant's charges under -80. |
| -81 | Minimum Surgical Assistant | Minimum assistance provided by a surgeon; less than full assistant role. |
| -82 | Assistant Surgeon — When Qualified Resident Not Available | Applicable in teaching hospital settings when a qualified resident is not available. |
| -AS | PA, NP, CNS as Assistant Surgeon (HCPCS) | Non-physician practitioners assisting in surgery. Different from -80 — used for NPP assistants. |
| -LT / -RT | Left / Right Side | Append to lateralized procedures. Example: right inguinal hernia repair = 49505-RT. |
�� IMAGE PLACEHOLDER: Image 2: A professionally designed reference chart showing the most important surgical billing modifiers — -24, -25, -57, -58, -78, -79, -80 — with a brief description and use case for each. Caption: General Surgery Billing Services — The Modifier Reference Card Every Surgical Coder Needs.
In general surgery medical billing, the surgical approach is not a minor detail, it is a code-determinative factor. Using the wrong approach code is not a modifier error; it is miscoding that can result in claim denial, incorrect reimbursement, and audit exposure.
| Procedure | Laparoscopic CPT Code | Open CPT Code |
|---|---|---|
| Cholecystectomy | 47562 | 47600 |
| Appendectomy | 44950 (laparoscopic not always separately coded) | 44950/44960 |
| Colectomy (partial) | 44204 | 44140 |
| Inguinal hernia repair (initial) | 49650 | 49505/49507 |
| Ventral/incisional hernia repair | 49652 | 49560 |
| Nissen fundoplication | 43280 (laparoscopic) | 43327 (open) |
| Splenectomy | 38120 | 38100 |
| Adrenalectomy | 60650 | 60540 |
| Gastric bypass (Roux-en-Y) | 43644 | 43846 |
| Sleeve gastrectomy | 43775 | N/A (typically only laparoscopic) |
According to our experience the prior authorization (PA) is one of the most important and most time-consuming administrative responsibilities in general surgery billing services. For elective procedures, operating without a valid prior authorization from the payer is virtually guaranteed to result in a zero-payment denial.
| General Surgery Procedure | Medicare Fee-for-Service | Commercial / Medicare Advantage |
|---|---|---|
| Laparoscopic cholecystectomy (elective) | Generally no PA | Almost always requires PA |
| Emergency cholecystectomy | No PA required | Usually exempt if documented emergency |
| Elective hernia repair | No PA (Medicare FFS) | Commonly requires PA |
| Bowel resection (elective) | No PA (Medicare FFS) | Almost always requires PA |
| Bariatric surgery (sleeve/bypass) | CMS requires clinical criteria | Always requires PA + committee review |
| Thyroid and parathyroid surgery | No PA (Medicare FFS) | Usually requires PA |
| Mastectomy for cancer | No PA (Medicare FFS) | Usually requires PA |
| Breast reconstruction post-mastectomy | No PA (Medicare FFS; WHCRA applies) | Typically requires PA |
| Adrenalectomy | No PA (Medicare FFS) | PA required in most plans |
| Soft tissue tumor excision > 3 cm | No PA (Medicare FFS) | Commonly requires PA |
�� Tip: Get Authorization for the Anticipated Procedure AND Possible Complications
A common problem in general surgery billing: you get PA for a laparoscopic cholecystectomy (47562) but the case converts to open (47600), or you find an unexpected common bile duct stone requiring ERCP. The PA you obtained does not cover these additional procedures. Train your pre-authorization team to request broader authorization language that covers likely related procedures, conversion to open, intraoperative cholangiography (CPT 47563), and possible bile duct exploration. Document all authorization confirmations by number and date in the operative scheduling record.
Medicare and Medicaid are major payers for general surgery practices, particularly for older adult patients presenting with gallbladder disease, hernia, colorectal conditions, and cancer. Each program has specific billing rules that surgical practices must follow.
You know that denial management in general surgery billing is not a passive activity, it is an active revenue protection strategy. Every denied claim is recoverable revenue. But only if your team identifies the root cause quickly and appeals within the payer’s filing window.
| Denial Reason | Denial Code | Root Cause in General Surgery | Corrective Action |
|---|---|---|---|
| Missing Prior Authorization | CO-15 | Elective procedure performed without PA or PA number omitted from claim | Implement PA tracking system; include auth number on every elective surgical claim |
| Global Period Bundling | CO-97 | Post-op service billed without correct modifier during global period | Train staff on global periods; apply -24, -58, -78, or -79 modifier as appropriate |
| Wrong Approach Code | CO-11 | Open code billed for laparoscopic procedure (or vice versa) | Implement operative note vs. code audit at charge entry; coder must review op note |
| Medical Necessity Denied | CO-50 | ICD-10 code does not support CPT procedure code | Use most specific ICD-10; link post-op diagnosis to procedure — not pre-op |
| Modifier Missing or Wrong | CO-4 | Bilateral procedure without -50; multiple procedures without -51 | Implement modifier checklist at charge capture; audit claims pre-submission |
| NCCI Bundling Conflict | CO-97 | Two procedures submitted that are bundled per NCCI edits | Run NCCI check before submission; apply -59 or X-modifier with documentation |
| Assistant Surgeon Not Covered | CO-5 | Medicare does not cover assistant surgeon for this procedure | Verify Medicare assistant surgeon approval for CPT code before surgery |
| Timely Filing Exceeded | CO-29 | Claim not submitted within payer's filing window | Implement claim submission monitoring; submit within 48-72 hours of service |
| Patient Ineligible | CO-27 | Insurance terminated or patient not covered on date of service | Verify eligibility day-of-service for all scheduled surgical cases |
�� Tip: Build a 72-Hour Claim Submission Rule for Surgery
In general surgery billing, every day a claim sits unsubmitted after an operative case is a day you are not getting paid. Implement a firm practice policy: all surgical claims must be coded, scrubbed, and submitted within 72 hours of the procedure.
General surgeons are not only billing for operative procedures in the USA, but they also bill for office-based Evaluation and Management (E/M) services, pre-operative consultations, post-discharge follow-up, and hospital visits. Each has its own billing rules within the context of the global surgical package.
| E/M Scenario | Modifier Required | Billing Rule |
|---|---|---|
| Office visit — decision for major surgery, same day as surgery | Modifier -57 | Required to unbundle from 90-day global; bill the E/M + -57 |
| Office visit — decision for minor surgery (0/10-day global) | Modifier -25 | Required to bill E/M same day as procedure |
| Post-op visit — unrelated condition during global period | Modifier -24 | Document clearly that condition is unrelated to surgery |
| Hospital visit during global period — unrelated | Modifier -24 | E/M for conditions unrelated to surgery are separately billable |
| Transfer of post-op care | Modifiers -54/-55 | Primary surgeon bills -54; receiving physician bills -55 |
| New patient consult (office) | 99202-99205 | No longer separately payable by Medicare; use standard E/M codes |
| Hospital admission (inpatient initial) | 99221-99223 | Bill when admitting the patient; document MDM level |
| Subsequent hospital visit during global | Included in global package | Do NOT bill separately for routine post-op hospital visits |
Measuring the right metrics is what separates a well-managed general surgery revenue cycle from one that is constantly reactive. These are the KPIs that define high-performing general surgery medical billing services.
| KPI Metric | General Surgery Benchmark | What It Measures |
|---|---|---|
| Clean Claim Rate | > 95% | % of surgical claims accepted without error on first submission |
| Denial Rate | < 5% | % of claims denied; 7-12% without active management in general surgery |
| Days in A/R | < 35 days | Average time from surgery to payment — longer = workflow problem |
| Net Collection Rate | > 96% | % of collectible surgical revenue actually collected |
| A/R > 90 Days | < 10% of total A/R | Aging surgical A/R signals systemic denial or follow-up gaps |
| Claim Submission Lag | < 72 hours | Days between surgery date and claim submission |
| Authorization Denial Rate | < 2% | PA-related denials — should be near zero with proper workflow |
| Modifier Error Rate | < 1% of surgical claims | Modifier errors — tracked via denial CO-4; signals coder training gap |
| Cost to Collect | 5-9% of collections | Total billing cost as % of surgical revenue collected |
| First-Pass Resolution Rate | > 90% | % of denied claims resolved without second-level appeal |
Keeping up with annual CPT and fee schedule changes is a revenue protection strategy in general surgery. Here is what you need to know for 2026.
The global surgical package includes the pre-operative evaluation on the day of surgery (and one day before for major procedures), the intraoperative services, all routine post-operative care within the global period, and complications that do not require a return to the OR. Separate services, unrelated conditions, return-to-OR complications, diagnostic tests, and staged procedures — can be billed separately with the correct modifier.
Use modifier -24 for unrelated E/M services during the global period; -58 for planned staged procedures returning to the OR; -78 for unplanned returns to the OR for complications related to the original surgery; and -79 for unrelated procedures performed during the global period. Using the wrong modifier or no modifier results in bundling denials.
Bill only the open procedure code (since that is what was ultimately performed). Do not bill both the laparoscopic and open codes. Document the conversion clearly in the operative note and consider modifier -22 (Increased Procedural Services) if the conversion significantly increased complexity and operative time, with full supporting documentation attached.
Yes. House of Outsourcing provides general surgery billing services for professional (physician) charges, and our team works with facility billing teams to coordinate claims for ambulatory surgery center (ASC) and hospital outpatient department (HOPD) encounters. Contact us to discuss your specific practice structure and billing needs at www.houseofoutsourcing.com.
Get a free assessment from our billing experts
